These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8834030)

  • 1. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.
    Ikeda T; Tozuka S; Noguchi O; Kobayashi F; Sakamoto S; Marumo F; Sato C
    J Hepatol; 1996 Jan; 24(1):88-94. PubMed ID: 8834030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
    Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
    Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
    Almasio PL; Floreani A; Chiaramonte M; Provenzano G; Battezzati P; Crosignani A; Podda M; Todros L; Rosina F; Saccoccio G; Manenti F; Ballardini G; Bianchi FP; Scheuer PJ; Davies SE; Craxì A
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1645-52. PubMed ID: 11121914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
    Angulo P; Dickson ER; Therneau TM; Jorgensen RA; Smith C; DeSotel CK; Lange SM; Anderson ML; Mahoney DW; Lindor KD
    J Hepatol; 1999 May; 30(5):830-5. PubMed ID: 10365809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol.
    Bonis PA; Kaplan M
    Gastroenterology; 1999 Aug; 117(2):395-9. PubMed ID: 10419921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
    Oka H; Toda G; Ikeda Y; Hashimoto N; Hasumura Y; Kamimura T; Ohta Y; Tsuji T; Hattori N; Namihisa T
    Gastroenterol Jpn; 1990 Dec; 25(6):774-80. PubMed ID: 1980654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
    Kaplan MM; Bonder A; Ruthazer R; Bonis PA
    Dig Dis Sci; 2010 Nov; 55(11):3207-17. PubMed ID: 20559727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone.
    Buscher HP; Zietzschmann Y; Gerok W
    J Hepatol; 1993 Apr; 18(1):9-14. PubMed ID: 8101853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.
    Roda E; Azzaroli F; Nigro G; Piazza F; Jaboli F; Ferrara F; Liva S; Giovanelli S; Miracolo A; Colecchia A; Festi D; Mazzeo C; Bacchi L; Roda A; Mazzella G
    Dig Liver Dis; 2002 Jul; 34(7):523-7. PubMed ID: 12236487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.
    Wolfhagen FH; van Hoogstraten HJ; van Buuren HR; van Berge-Henegouwen GP; ten Kate FJ; Hop WC; van der Hoek EW; Kerbert MJ; van Lijf HH; den Ouden JW; Smit AM; de Vries RA; van Zanten RA; Schalm SW
    J Hepatol; 1998 Nov; 29(5):736-42. PubMed ID: 9833911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.
    Wouters RS; Bos LP; Engels LG
    Neth J Med; 1990 Aug; 37(1-2):21-3. PubMed ID: 2215828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment.
    Kaplan MM; DeLellis RA; Wolfe HJ
    Ann Intern Med; 1997 May; 126(9):682-8. PubMed ID: 9139553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
    Poupon RE; Eschwège E; Poupon R
    J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
    Wolfhagen FH; van Buuren HR; Schalm SW
    Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study.
    Nakai S; Masaki T; Kurokohchi K; Deguchi A; Nishioka M
    Am J Gastroenterol; 2000 Jan; 95(1):326-7. PubMed ID: 10638623
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis.
    Shibata J; Fujiyama S; Honda Y; Sato T
    J Gastroenterol Hepatol; 1992; 7(3):277-82. PubMed ID: 1611015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.